Public Company News

SEMIFIVE Partners with Niobium to Develop FHE Accelerator, Driving U.S. Market Expansion

* Reinforces leadership as a trusted partner in specialized SoC design * Diversifies the ASIC portfolio with highly complex private computing solutions SEOUL, South Korea, Feb. 19, 2026 /PRNewswire/ -- SEMIFIVE, a leading global provider of custom AI semiconductor (ASIC) solutions, announced t...

2026-02-19 13:52 6619

MicroCloud Hologram Inc. Quantum Intelligent Interconnected Fault-Tolerant Consensus Algorithm Achieves Collaborative Control of Financial Internet Nodes

SHENZHEN, China, Feb. 18, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, proposed a quantum intelligent interconnected fault-tolerant consensus algorithm that deeply integrates quantum computing technology into the consensu...

2026-02-19 01:00 8075

Datasea Announces Foundational Research Breakthrough in Ultrasonic-Enhanced Nanoscale Precision Control

Establishing an Engineering-Level Core Technology for Next-Generation Semiconductor Manufacturing Applications BEIJING, Feb. 18, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based technology company specializing in acoustic high-tech solutions and 5G+AI ...

2026-02-18 22:30 9012

WiMi Studies Hybrid Quantum-Classical Inception Neural Network Model for Image Classification

BEIJING, Feb. 18, 2026 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, proposed a brand-new technological innovation—a hybrid quantum-classical Inception neural network model for image class...

2026-02-18 21:00 8907

BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing

XI'AN, China, Feb. 17, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON"or the "Company"), a leading bio-ingredient provider for the natural health and personal care industries, today announced the establishment of the BON & Pilot Joint Laboratory for Natural Ingredients and Bio-...

2026-02-17 22:00 9644

Nature's Miracle Holding Inc. Begins Offering Made-in-USA Grow Lights Through Exclusive Agreement with Megaphoton USA LLC

ONTARIO, Calif., Feb. 17, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company"), a provider of equipment and services for the controlled environment agriculture (CEA) industry, today announced it has signed an exclusive supply agreement with MegaphotonU...

2026-02-17 21:30 6193

Marvion Inc. Announces Two New Investors, Further Strengthening Capital Base and Advancing Strategic Growth

HONG KONG, Feb. 17, 2026 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) (the "Company" or "Marvion") today announced that onFebruary 2, 2026, the Company entered into Stock Purchase Agreements with two new investors. The transactions were duly disclosed through a Form 8-K filing in accordance with ap...

2026-02-17 21:18 11830

TGE's Latest Movie "Scare Out" Surpasses US$ 14.5 Million in Pre-Sales

PARIS, NEW YORK and LONDON, Feb. 17, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE's latest m...

2026-02-17 20:30 5648

Lufax Announces Filing of Its Annual Report on Form 20-F

SHANGHAI, Feb. 17, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced  that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exch...

2026-02-17 20:20 8373

Lufax Announces Changes of Directors and Senior Management

SHANGHAI, Feb. 17, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced leadership transitions and new appointments to its Board of Directors and senior management. Mr. Yong Suk Cho ("Mr. Cho") ...

2026-02-17 20:20 9831

Farmmi Inc. (NASDAQ: FAMI) Intelligent Marketing Subsidiary Bluesage Off to a Winning Start, Formally Signs First Global Client Service Contract

LISHUI, China, Feb. 17, 2026 /PRNewswire/ -- NASDAQ-listed Farmmi Inc. (NASDAQ: FAMI) (hereinafter referred to as "Farmmi" or the "Company") is pleased to announce that its newly established wholly-owned intelligent marketing subsidiary, Bluesage Marketing Inc. ("Bluesage"), formally signed its f...

2026-02-17 20:00 4953

Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial

HIGHLIGHTS * Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. * The study was led by Prof Louise Emmett at St Vincent's Hospital Sydney, and the abstract was accepted for oral presentation at the upcoming European Association of Urology (...

2026-02-16 22:03 9987

CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial

* CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA)to initiate a Phase II clinical trial inpatients with advanced solid tumors. This marks a significant milestone in the global development of thi...

2026-02-16 08:10 8461

U Power to Present at OTC Markets AI & Technology Investor Conference on February 19

BANGKOK, Feb. 13, 2026 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) ("U Power" or the "Company"), a provider of AI-integrated solutions for next-generation energy grids and intelligent transportation systems, today announced that its management team will present at the OTC Markets AI & Technol...

2026-02-14 01:00 13117

THE SEVEN DEADLY SINS: ORIGIN CONFIRMS LAUNCH DATE; PLAY EARLIER MARCH 16 ON PLAYSTATION®5 AND STEAM

Grand Launch with Mobile Expansion to Follow on March 23 SEOUL, South Korea, Feb. 13, 2026 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality games, announced today the official launch schedule for its new open world RPGThe Seven Deadly Sins: Origin. Players on PlayStat...

2026-02-14 00:00 8725

Hello Group to Report Fourth Quarter and Fiscal Year 2025 Results on March 18, 2026

BEIJING, Feb. 13, 2026 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) (the "Company"), a leading player inAsia's online social networking space, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025 before U.S. markets...

2026-02-13 19:00 7378

Vipshop to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

GUANGZHOU, China, Feb. 13, 2026 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), today announced that it plans to release its fourth quarter and full year 2025 financial results onThursday, February 26, 2026...

2026-02-13 18:00 6820

Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 5, 2026

BEIJING, Feb. 13, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company inChina focused on enabling lifelong learning through AI-powered solutions, today announced that it will report its financial results for the fourth qua...

2026-02-13 17:00 6333

HanchorBio Receives FDA Orphan Drug Designation for HCB101 in Gastric Cancer

First SIRPα-IgG4 Fc Fusion Protein Granted Orphan Status in Gastric Cancer TAIPEI, SHANGHAI and SAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases,...

2026-02-13 14:04 7473

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 12, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent",HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2026-02-13 08:00 7977
1 ... 37383940414243 ... 766